Overview

Quantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to Treatment

Status:
ENROLLING_BY_INVITATION
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
This is a three-armed open investigational study that aims to differentiate, quantify, and categorize abnormal eye movements and upper limbs movements in patients with Parkinson's disease. The study is using investigational non-invasive devices for that reason including ANLIVA Hand Movement and ANLIVA Eye Movement.
Phase:
NA
Details
Lead Sponsor:
Stardots AB